Poor Ovarian Response Unit

Anti-müllerian hormone (AMH) is no longer a crystal ball

Anti-müllerian hormone (AMH) is used in reproductive medicine as an ovarian reserve marker. This hormone is detected using a simple blood analysis and, in conjunction with a follicle count ultrasound scan on the ovaries, it helps us to predict a patient’s response to stimulation. This is mainly true when patients have a limited prognosis.

In any case, despite how […]

2019-07-01T09:02:31+02:005 de July de 2019|0 Comments

Why hasn’t my assisted reproduction treatment worked?

The miracle of conception involves an intimate union between the ova and spermatozoon, appropriate evolution of the fertilised embryo and, furthermore, an ideal environment inside the uterus so that implantation can take place. Whilst this process might seem simple, it is much more complex than we might think, particularly in human beings. Only 30% of our conceptions end in […]

2019-06-13T09:00:34+02:0014 de June de 2019|0 Comments

Poor ovarian reserve; which means of diagnosis is the most reliable?

If we take into account that women’s oocytes develop before they are even born and that, after birth, the oocytes progressively decrease in number until they run out completely when women reach the menopause, the concept of ovarian reserve refers to the oocytes that are in a woman’s ovaries at any given time.

Assessing ovarian reserve is particularly important if […]

2019-05-31T08:53:37+02:0031 de May de 2019|0 Comments

What tests do I need to have before egg donation treatment?

Egg donation has become an option for women who, for whatever reason, can no longer use their own ova. For example, due to poor ovarian reserve, poor oocyte quality and premature menopause.

The process is widely used in Spain. As well as exceeding organ
donations and transplants in number, we also have the largest number of egg
donors in Europe.

It […]

2019-02-15T09:45:38+02:0015 de February de 2019|0 Comments

Progress in treatment for patients with poor ovarian response

Personalising courses of treatment is undoubtedly currently the
most important area of change in the field of medicine. A specific strategy should be designed
depending on each patient’s individual characteristics.

One of the key areas for developing personalised medical healthcare is the use of pharmacogenetics. A patient needs different doses or types of pharmaceutical drugs depending on certain genetic variations. […]

2019-01-23T10:37:32+02:0025 de January de 2019|0 Comments

Obesity and fertility

The extent of the issue
Obesity is a public health issue both in the general population and in women of childbearing age. The figures are a proof of this and, far from improving, the problem has been getting progressively worse over the last few years.
Maternal obesity in the United States of America was calculated to be 7% in 1980 and had risen up to 24% by 1999. If we take into account both obesity and excess weight, the available data indicates that the figures were 37.1% in 1999 and 40.5% in 2003.
The NHANES (National Health and Nutrition Examination Survey) reveals obesity figures (BMI or body mass index ≥ 30 kg/m2) in women of reproductive age (20 to 39 years of age) of 31.9%.
In other words, one in every three women of a fertile age is obese. […]

2018-12-07T10:06:37+02:007 de December de 2018|0 Comments

Breast cancer and fertility

Breast cancer is the most common malignant tumour found in women and it is the main cause of death in women due to cancer in the world.
Over the last few years, there has been an increase in this pathology in younger women and, at the same time, treatment has taken breast cancer survival rates to almost 85%. These facts and a pronounced trend towards delaying motherhood has generated a group of women whose ability to reproduce has been negatively affected before they have had the chance to turn their dream of becoming a mother into a reality. […]

2018-10-17T09:07:54+02:0019 de October de 2018|0 Comments

The advantages of comprehensive chromosome screening (PGS/PGT-A/CCS) in women of an advanced maternal age

Women currently seek guidance on reproduction at a much older age than they did some years ago. As a result, amongst the women who undergo fertility treatment, there is a significant group of women of an advanced age and their prognosis is poorer. This is a huge challenge for reproduction specialists. […]

2018-09-06T09:36:01+02:007 de September de 2018|0 Comments

What is oestradiol? What is this sex hormone’s role?

Hormones are messengers that are present in all multicellular organisms – be they animal or plant organisms – that coordinate the functions of each part of that organism.
The sex hormones par excellence are oestradiol in females and testosterone in males. However, the adrenal glands in men and women produce both hormones and they are both necessary for normal development of the two sexes. […]

2018-08-08T14:20:13+02:0010 de August de 2018|0 Comments

Have I got poor ovarian response? How should I deal with it?

A patient can be classified as having poor response when the number of oocytes obtained during a cycle of in vitro fertilisation is under what was expected. The criteria generally used to label a patient as a poor responder is when 3 or fewer oocytes are retrieved and she has incredibly low ovarian reserve markers (fundamentally, AMH and AFC). […]

2018-08-01T11:49:34+02:003 de August de 2018|0 Comments
Do you need help?